Nelson license agreement with B-W
Executive Summary
Company announced Sept. 19 that Burroughs-Wellcome exercised option to enter exclusive worldwide license agreement for development and marketing of a topical non-steroidal for treatment of psoriasis. Product will contain Nelson's Azone to enhance penetration through the skin